Dr Na Rong and Professor Li Xue (IMAGE)
Caption
A study from HKUMed demonstrates that prostate-specific antigen (PSA) screening can significantly reduce the incidence of advanced-stage prostate cancer and mortality rate. The research is led by Dr Na Rong (left) from the Department of Surgery, and Professor Li Xue from the Department of Medicine, both under the School of Clinical Medicine at HKUMed.
Credit
The University of Hong Kong
Usage Restrictions
N/A
License
Original content